BioXcel Therapeutics Enhances Leadership with Appointment of Chetan D. Lathia, Ph.D. as Senior Vice President, and Head of Translational Medicine, Clinical Pharmacology and Regulatory Affairs

BioXcel Therapeutics Appoints Dr. David C. Hanley as Vice President and Head of Global Pharmaceutical Development and Operations

20th Annual Global Investment Conference

Sep 5, 2018 • 10:50am EDT

38th Annual Canaccord Genuity Growth Conference

Aug 9, 2018 • 2:00pm EDT